To further demonstrate the molecular mechanism of H19 in modulating post-translational modifications (PTM) other than Ub-DMD, we reasoned that BMD would serve as a suitable candidate given the notion that BMD patients generally harbor reduced, yet detectable DMD protein levels [18]. This evidence concerns the gene DMD and Becker muscular dystrophy.